Search
for
Sort by
Research 601–630 of 1000+
- A Method to Monitor Dutasteride in Rat Plasma Using Liquid-Liquid Extraction and Multiple Reaction Monitoring: Comparisons and Validation
- Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent
- Long-term efficacy and safety of the dual 5-alpha reductase blocker dutasteride on male androgenetic alopecia patients
- Effect of Solvent on Stereoselectivity in Pd/C (Type 39K)-Catalyzed Hydrogenation of Methyl 3-Oxo-4-aza-5-androstene-17-carboxylate, A Key Intermediate for Finasteride and Dutasteride
- Reply to Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Formulation of a film-coated dutasteride tablet bioequivalent to a soft gelatin capsule (Avodart®): Effect of γ-cyclodextrin and solubilizers
- A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
- Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS
- Development and Characterization of Dutasteride Bearing Liposomal Systems for Topical Use
- Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial
- Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
- Clinical, trichoscopic, and folliscopic identification of the impact of metabolic syndrome on the response to intradermal dutasteride 0.02% injection in patients with female pattern hair loss: a prospective cohort study
- Finasteride versus dutasteride: a real-world economic evaluation.
- Body mass index as a potential confounder in dutasteride and fertility studies
- Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
- Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia
- Dutasteride nanoemulsion preparation to inhibit 5-alpha-hair follicle reductase enzymes in the hair follicle; an ex vivo study.
- Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis?
- Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
- Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study
- Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
- Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study